Shiro Mita
Gründer bei M's Science Corp.
Profil
Shiro Mita is the founder of M's Science Corp.
established in 2000, where he holds the title of Representative Director.
Dr. Mita obtained a doctorate degree from the University of Tokyo.
Aktive Positionen von Shiro Mita
| Unternehmen | Position | Beginn |
|---|---|---|
M's Science Corp.
 M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Gründer | 01.11.2000 |
Ehemalige bekannte Positionen von Shiro Mita
| Unternehmen | Position | Ende |
|---|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Direktor/Vorstandsmitglied | - |
| SANTEN PHARMACEUTICAL CO., LTD. | Direktor/Vorstandsmitglied | - |
| ACUCELA INC | Direktor/Vorstandsmitglied | - |
| Keio University | Corporate Officer/Principal | - |
Ausbildung von Shiro Mita
| University of Tokyo | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
M's Science Corp.
M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Commercial Services |
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
